Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (26)

2024

  1. Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery

    Open Respiratory Archives, Vol. 6, Núm. 3

2023

  1. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 59, Núm. 2, pp. 90-100

  2. Highlights 56th SEPAR Congress

    Open Respiratory Archives, Vol. 5, Núm. 3

  3. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

2022

  1. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 135-141

  2. [Translated article] Smoking Cessation Units as a Source of COPD Diagnoses: Project 1000-200

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. T264-T267

2021

  1. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

    Chest, Vol. 159, Núm. 1, pp. 58-72

  2. Smoking Cessation Units as a Source of COPD Diagnoses: Project 1000-200

    Archivos de Bronconeumologia

2019

  1. An international perspective on hospitalized patients with viral community-acquired pneumonia

    European Journal of Internal Medicine, Vol. 60, pp. 54-70

  2. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

    Journal of Infection, Vol. 79, Núm. 4, pp. 300-311

2018

  1. A Composite of Functional Status and Pneumonia Severity Index Improves the Prediction of Pneumonia Mortality in Older Patients

    Journal of General Internal Medicine, Vol. 33, Núm. 4, pp. 437-444

  2. Adaptation of antibiotic treatment to clinical practice guidelines in patients aged ≥65 years hospitalised due to community-acquired pneumonia

    Epidemiology and Infection, Vol. 146, Núm. 14, pp. 1870-1877

  3. Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain

    Journal of Asthma, Vol. 55, Núm. 4, pp. 391-401

  4. Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study

    ERJ Open Research, Vol. 4, Núm. 4

2017

  1. Asthma in older people hospitalized with influenza in Spain: A case-control study

    Allergy and Asthma Proceedings, Vol. 38, Núm. 4, pp. 277-285

  2. Costs associated with influenza-related hospitalization in the elderly

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416

  3. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain

    PLoS ONE, Vol. 12, Núm. 2

  4. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 450-455

2016

  1. Effect of influenza vaccination on the prognosis of hospitalized influenza patients

    Expert Review of Vaccines, Vol. 15, Núm. 3, pp. 425-432

  2. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

    Human Vaccines and Immunotherapeutics, Vol. 12, Núm. 7, pp. 1891-1899